Shangri-La Tibetan Pharmaceuticals, Inc. - FORM S-1/A - EX-21.1 - EXHIBIT 21.1 - October 18, 2010

Attached files

file filename
S-1/A - AMENDMENT #4 TO FORM S-1 - Shangri-La Tibetan Pharmaceuticals, Inc.ds1a.htm
EX-4.1 - EXHIBIT 4.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex41.htm
EX-1.1 - EXHIBIT 1.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex11.htm
EX-5.2 - EXHIBIT 5.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex52.htm
EX-5.1 - EXHIBIT 5.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex51.htm
EX-10.1 - EXHIBIT 10.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex101.htm
EX-10.6 - EXHIBIT 10.6 - Shangri-La Tibetan Pharmaceuticals, Inc.dex106.htm
EX-99.1 - EXHIBIT 99.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex991.htm
EX-23.1 - EXHIBIT 23.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex231.htm
EX-99.2 - EXHIBIT 99.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex992.htm
EX-10.21 - EXHIBIT 10.21 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1021.htm
EX-10.20 - EXHIBIT 10.20 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1020.htm

Exhibit 21.1

Subsidiaries and Affiliate of Registrant

The follow are the Registrant and its subsidiaries:

Registrant (British Virgin Islands):

Tibet Pharmaceuticals, Inc. (formerly Shangri-La Tibetan Pharmaceuticals, Inc.)

Subsidiary (Hong Kong):

China Tibetan Pharmaceuticals Limited

Subsidiary (PRC)

Yibo Information Consulting (Shenzhen) Company Ltd.

Affiliate (PRC)

Yunnan Shangri-La Tibetan Pharmaceutical Group Limite (entity controlled pursuant to contractual arrangements with Registrant’s wholly owned subsidiary, Yibo Information Consulting (Shenzhen) company Ltd.)

Shangri-La Tibetan Pharmaceuticals, Inc. Reports

Also read